Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-085648

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 14, 2015S1,861$20.0881D30,810ISee Footnote
Common StockF1,F3Dec 14, 2015S100$20.0881D1,657ISee Footnote
Common StockF1,F4Dec 14, 2015S1,919$20.0881D31,763ISee Footnote
Common StockF1,F5Dec 14, 2015S42$20.0881D702ISee Footnote
Common StockF6,F2Dec 15, 2015S25,894$20.1041D4,916ISee Footnote
Common StockF6,F3Dec 15, 2015S1,392$20.1041D265ISee Footnote
Common StockF6,F4Dec 15, 2015S26,697$20.1041D5,066ISee Footnote
Common StockF6,F5Dec 15, 2015S589$20.1041D113ISee Footnote
Common StockF7,F2Dec 16, 2015S4,916$19.5656D0ISee Footnote
Common StockF7,F3Dec 16, 2015S265$19.5656D0ISee Footnote
Common StockF7,F4Dec 16, 2015S5,066$19.5656D0ISee Footnote
Common StockF7,F5Dec 16, 2015S113$19.5656D0ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Following the transaction reported in this Form 4, Wilfred Jaeger, as a director of the Issuer, will remain subject to Section 16.